Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
暂无分享,去创建一个
D. Sargent | M. Teufel | M. Ychou | E. Van Cutsem | R. Goldberg | H. Lenz | J. Tabernero | A. Grothey | Y. Humblet | M. Jeffers | O. Bouché | S. Siena | L. Mineur | A. Falcone | T. Yoshino | A. Adenis | C. Barone | A. Sobrero | D. Laurent | A. Wagner